Issue 58, 2018

Glutathione-responsive homodithiacalix[4]arene-based nanoparticles for selective intracellular drug delivery

Abstract

Glutathione-responsive, paclitaxel-loaded nanoparticles based on homodithiacalix[4]arene were successfully developed, exhibiting selective drug release in cancer cells.

Graphical abstract: Glutathione-responsive homodithiacalix[4]arene-based nanoparticles for selective intracellular drug delivery

Supplementary files

Article information

Article type
Communication
Submitted
24 Jun 2018
Accepted
26 Jun 2018
First published
28 Jun 2018

Chem. Commun., 2018,54, 8128-8131

Glutathione-responsive homodithiacalix[4]arene-based nanoparticles for selective intracellular drug delivery

Q. Cheng, H. Yin, C. Sun, L. Yue, Y. Ding, W. Dehaen and R. Wang, Chem. Commun., 2018, 54, 8128 DOI: 10.1039/C8CC05031G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements